Summary
NASDAQ Biotechnology is a stock index: one number that says how a chosen group of companies is doing together. An index cannot be bought itself; you buy a fund that tracks it.
What speaks for it
- Average yearly growth over the last ten years: 9.7%.
What to watch
- In the last five years it once dropped by 38% from its high.
An index has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company.
Price
Performance
- 1 month
- +0.8%
- 3 months
- +8.4%
- This year
- +24%
- 1 year
- +37%
- 3 years
- +89%
- 5 years
- +43%
- 10 years
- +152%
Where is it within the last year?
Near the yearly high- Against the 50-day average
- +0.3%
- Against the 200-day average
- +12%
It is 4.5% below its highest and 36% above its lowest of the last year. The long-term trend points up: it is above its 200-day average.
How has it done?
Growing over the long run- A year on average, 10 years
- +9.7%
- Deepest drop
- -38%
- Yearly volatility
- 22%
Average yearly growth over the last ten years: 9.7%. Deepest drop in these years: 38% below the earlier high.